KICK-IN GOAL - IDORSIA | Market Closed - Swiss Exchange 11:20:00 2024-06-04 EDT | ||
| 43.65 CHF | -8.11% |
|
| Current month | -6.43% | ||
| 1 month | +19.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IDORSIA LTD
Latest news about IDORSIA LTD
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 43.65 | -8.11% |
| 24-06-03 | 47.5 | +1.82% |
Delayed Quote Swiss Exchange
Last update June 04, 2024 at 11:20 am
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | IDORSIA LTD |
| Issuer | UBS |
| KOMSDU | |
| ISIN | CH1274478374 |
| Date issued | 2023-07-05 |
| Strike | 6.51 CHF |
| Maturity | 2024-07-05 (25 Days) |
| Parity | 0.01 : 1 |
| Emission price | 100 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 93.5 CHF |
|---|---|
| Lowest since issue | 28.54 CHF |
| Spread | 3 CHF |
| Spread % | 0.74% |
Company Profile
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
Sector
-
Consensus: Idorsia Ltd
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
2.18
CHF
Average target price
1.692
CHF
Spread / Average Target
-22.36%
- Stock Market
- Certificates
- KOMSDU Certificat
